At ESC Congress 2023 we will be 'joining forces to protect the heart' and create the future of cardiology – a future where everything is possible.
Dr Jorg Taubel will be attending in person along with Dr Julian Gilmore from the Royal Free London NHS Foundation Trust who will be presenting ‘ATTRibute-CM: acoramidis (AG10) in patients with transthyretin amyloid cardiomyopathy’
Richmond Pharmacology Appoints John Hotti as Chief Technology Officer
April 22, 2026
Richmond Pharmacology is pleased to announce the appointment of John Hotti as Chief Technology Officer (CTO), strengthening the company’s leadership in technology-enabled clinical research.
By clicking “Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.